Key facts
- This page summarizes GILEAD SCIENCES, INC.'s Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 May 2026, 20:55.
GILEAD SCIENCES, INC. - 26 May 2026 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ASMB
- Reported as of
- 26 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 May 2026, 20:55:23 UTC
- Prior SEC filing
- 17 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
GILEAD SCIENCES, INC. filed Form 4 for ASSEMBLY BIOSCIENCES, INC. (ASMB) on 27 May 2026.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0000882095
Primary reporting owner
GILEAD SCIENCES, INC.
- Relationship
- 10%+ Owner
- Address
- 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
- Signature date
- 27 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASMB
transaction
Common Stock
Award
- Transaction value
- Shares
- +471,698
- Change %
- +10%
- Price
- $26.50*
- Shares after
- 4,977,089
- Date
- 26 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.